A Pilot Study to Assess the Safety and Efficacy of Oral PTH (1-34) in the Treatment of Hypoparathyroidism
Phase of Trial: Phase II
Latest Information Update: 12 Oct 2015
Price : $35 *
At a glance
- Drugs Teriparatide (Primary)
- Indications Hypoparathyroidism
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- Sponsors Entera Bio
- 04 Aug 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 30 Dec 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 25 Jun 2014 New trial record